UGA Graduate student and Yale alumna. Enjoys science research, science communication, and all things wine or puppy related! Check out my scicomm projects below!
@DNLee5 I NEEDED to read this. Thank you so much for sharing! We met briefly at ABRCMS last year. I still haven’t finished, but took in several projects that have shown me what I want after my PhD. And I’ve felt guilty for that. Thanks for sharing your experience!
@Ologies@Mercedes_Hardin I also know an enologist! She’s defending her PhD in the next few weeks so I imagine is very busy right now! But I could put you in touch at some point!
A great read from @guardian with MiraKind's partner @Mygenneve discussing how health technology can help address the need for better access to menopause healthcare for women. #featurefriday#knowledgeispower#womenempoweringwomen
https://t.co/qDGFOGwT7I
✈️ tickets bought, so I might as well share the news!!!! I’m heading to Cali for 10 weeks this summer! I’ve accepted a Medical Communications internship at Genomic Health! It’s… https://t.co/483nzRSiYU
Mondays can be rough. Talking about menopause in the workplace can be rougher. It's time to start talking - menopause is a stage of life and shouldn't be a taboo topic. #menopausemonday
https://t.co/uXp50bZXqH
A recent groundbreaking study found a critical part in the body's immune system that can translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn's Disease within a few years. #Innovation 🤯 https://t.co/fcSzlh38J9
At MiraKind, we have proven that women who have the KRAS-variant benefit from hormone therapy as a protection against their cancer. With more than 70 years of findings that demonstrate the benefits of estrogen, we are glad to not be alone in raising awareness! 👏👏
One woman's story of finding support in a national group connecting knitters and crocheters with breast cancer survivors after her own breast cancer diagnosis. @KnittedKnockers#StrongerTogether#MotivationMonday
https://t.co/ZltSqsBKlE
"We're here to give one another a boost, one that sometimes only other people who know what it is that you're going through can give." #StrongerTogether ❤️
https://t.co/t0hb9idvLn
At MiraKind, we have proven that women who have the KRAS-variant benefit from hormone replacement treatment as a prevention against their cancer. With more than 70 years of findings that demonstrate the benefits of estrogen, we are not alone. https://t.co/RvHWGgVcth